Key facts
- Cellsense’s last known valuation is $20.0M (Oct 2025).
- It has raised $1.0M; the latest was Early Stage VC ($1.0M) in Oct 2025.
- Notable investors include Village Capital, VentureWell, 43North, ACCEL Program, Earthshot Innovation Challenge — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Cellsense
- ·The full record, as it builds
Funding rounds
No funding rounds for Cellsense are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cellsense
Developer of bio-embellishments intended for the design and beauty industries. The company transforms algae and cellulose into sustainable beads and beaded fabrics for the fashion, jewelry, and beauty industries and its proprietary material replaces sources of microplastics and heavy metal pollution while offering designers a wide range of brilliant colors, clarities, and properties such as fluorescence, enabling companies with cut in lead time of customized beaded products from weeks to days by eliminating expensive tooling and tedious manual labor from conventional processes
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 4
- Website
- cellsense.bio/
- Ownership
- Privately Held (backing)
Cellsense doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cellsense shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cellsense in its N-PORT filings yet. We sweep new filings monthly.